<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM FORM
10-Q FOR THE QUARTERLY PERIOD ENDED OCTOBER 31, 1996 AND IS QUALIFIED
IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENT.
</LEGEND>
<CIK> 0000316253
<NAME> ENZO BIOCHEM INC.
<MULTIPLIER> 1,000
       
                             
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          JUL-31-1997
<PERIOD-START>                             AUG-01-1996
<PERIOD-END>                               OCT-31-1996
<CASH>                                           23518
<SECURITIES>                                         0
<RECEIVABLES>                                    21713
<ALLOWANCES>                                    (6812)
<INVENTORY>                                       1736
<CURRENT-ASSETS>                                 42359
<PP&E>                                            8724
<DEPRECIATION>                                  (5741)
<TOTAL-ASSETS>                                   64210
<CURRENT-LIABILITIES>                             2705
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           231
<OTHER-SE>                                       60398
<TOTAL-LIABILITY-AND-EQUITY>                     64210
<SALES>                                           8005
<TOTAL-REVENUES>                                  8005
<CGS>                                             3619
<TOTAL-COSTS>                                     4725
<OTHER-EXPENSES>                                  3189
<LOSS-PROVISION>                                  1536
<INTEREST-EXPENSE>                               (478)
<INCOME-PRETAX>                                    139
<INCOME-TAX>                                        17
<INCOME-CONTINUING>                                122
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                       122
<EPS-PRIMARY>                                      .01
<EPS-DILUTED>                                      .01